Sensus Healthcare, Inc. (NASDAQ:SRTS) insider Kalman Fishman sold 4,183 shares of the business’s stock in a transaction on Friday, October 27th. The shares were sold at an average price of $6.00, for a total transaction of $25,098.00. Following the sale, the insider now directly owns 960,649 shares in the company, valued at $5,763,894. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Kalman Fishman also recently made the following trade(s):

  • On Wednesday, September 6th, Kalman Fishman sold 2,250 shares of Sensus Healthcare stock. The shares were sold at an average price of $6.00, for a total transaction of $13,500.00.
  • On Tuesday, September 5th, Kalman Fishman sold 5,762 shares of Sensus Healthcare stock. The shares were sold at an average price of $6.00, for a total transaction of $34,572.00.
  • On Thursday, August 24th, Kalman Fishman sold 5,378 shares of Sensus Healthcare stock. The shares were sold at an average price of $6.00, for a total transaction of $32,268.00.

Sensus Healthcare (NASDAQ:SRTS) last announced its quarterly earnings results on Thursday, August 3rd. The company reported ($0.06) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.08. Sensus Healthcare had a negative net margin of 13.31% and a negative return on equity of 16.40%. The firm had revenue of $4.97 million for the quarter, compared to analyst estimates of $4.50 million.

COPYRIGHT VIOLATION WARNING: This story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/11/02/kalman-fishman-sells-4183-shares-of-sensus-healthcare-inc-srts-stock.html.

An institutional investor recently bought a new position in Sensus Healthcare stock. B. Riley Financial Inc. purchased a new position in shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 104,794 shares of the company’s stock, valued at approximately $421,000. B. Riley Financial Inc. owned approximately 0.77% of Sensus Healthcare at the end of the most recent reporting period. 8.09% of the stock is currently owned by hedge funds and other institutional investors.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy.

Insider Buying and Selling by Quarter for Sensus Healthcare (NASDAQ:SRTS)

Receive News & Stock Ratings for Sensus Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare Inc. and related stocks with our FREE daily email newsletter.